TrialPloS one2015

First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.

Alice B Gottlieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.